NRXP: NRx Pharma Company Value to Net Income

Symbol and logo of brand NRx Pharmaceuticals Inc. (NRXP)

Historical price action serves as an indicator for NRx Pharmaceuticals (NRXP), which is creating a closed-loop therapy cycle for PTSD and depression backed by protected patents. The current P/E ratio stands at -4.00, while the small company's financial success depends on FDA approval of its new developments. The brand is highly valued by psychiatrists for seeking solutions to save patients in the most severe, critical conditions.

NRXP (NRx Pharmaceuticals, Inc.) Price to Earnings Ratio history from 07/04/2022 to 11/17/2026

Comprehensive metric breakdowns and analytics for nrxpharma.com (NRXP)

- price and consensus price forecast:
- market capitalization information:
Summary company analysis:NRx Pharmaceuticals Inc. - NRXP
Original product of NRx Pharmaceuticals

To identify undervalued assets, an investor must compare the market value of a security with its actual earnings per share. This calculation determines the cost of each unit of profit, which, in the context of NRx Pharmaceuticals (NRXP) and its promising developments in PTSD therapy, allows for an assessment of the market's confidence in the brand's future success via the company's P/E ratio.